Sign in
Active, not recruitingNo phase

Cryoneurolysis Prior to Total Knee Arthroplasty

Key facts

Who runs it
Esbjerg Hospital - University Hospital of Southern Denmark
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
100 people, planned
Started
30 Aug 2023
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Cryoneurolysis
  • Sham
Record updated
13 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Scheduled for unilateral, primary total knee arthroplasty
  • Age ≥ 18y
  • Written and oral understanding of Danish

Who cannot take part

  • Contraindications against ibuprofen or paracetamol, for example previous gastric ulcer, or known renal failure (eGRF < 60 ml/kg/1,73m2), known thrombocytopenia (< 100 bil/l); or against treatment with morphine
  • Previous recipient of cryoneurolysis for the knee
  • History of neuropathic pain
  • Uncontrolled serious disease (cancer, diabetes, etc.)
  • Disease associated with reactions to cold, such as cryoglobulinemia, cold urticarial and Reynaud's syndrome
  • Patients with daily use of high dose opioid (> oral morphine 30 mg/day or oxycodone 30 mg/day or tramadol 150 mg/day) or any use of other opioids including methadone and transdermal opioids

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Knee osteoarthritis is a major issue worldwide with limited treatment options. Many patients receive knee joint replacement surgery which is considered effective and safe. Nonetheless the period post-surgery is characterized by moderate to severe pain inhibiting early ambulation, motivation and range of motion, compromising rehabilitation, patient satisfaction, and overall outcomes. An optimal strategy of postoperative pain treatment after knee replacement surgery has not yet been established.

Read full original descriptionShow less

Recently, our research center and others have shown that is possible to target the nerves surrounding the knee with a novel treatment called cryoneurolysis. Cryoneurolysis apply low temperatures [-20°C ; -100°C] to a target nerve, which disrupts nerve function and provides potential pain relief. This suggest a potential for cryoneurolysis to significantly improve rehabilitation, reduce opioid intake and overall outcomes after knee replacement surgery.

The primary objective of the current project is to determine the effectiveness of cryoneurolysis in its proposed ability to reduce opioid intake and postoperative pain after knee replacement surgery.

The study is a randomized controlled study with two groups. Group CRYO receives cryoneurolysis prior to knee replacement surgery and group SHAM receives a sham treatment prior to knee replacement surgery. Both groups receive surgery, analgesics and postoperative rehabilitation as per usual.

Efficacy of treatment is evaluated using the change in opioid intake in the CRYO group compared to the SHAM group 14 days after knee replacement surgery. Participants will also be assessed at 90 and 180 days after knee replacement surgery and will include measures on pain, quality of life and function.

The 2 groups in the trial

  • CRYOTreatment being tested

    Receives cryoneurolysis treatment on the anterior femoral cutanous nerve and the infrapatellar branch of the saphenous nerve.

    Treatment: Cryoneurolysis

  • SHAMSham treatment, for comparison

    Receives similar procedures as in CRYO but with no freezing temperatures.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cryoneurolysis Prior to Total Knee Arthroplasty for the Management of Postoperative Pain; A Randomized, Sham-controlled, Trial
Record updated
13 October 2026